Abstract:Background This article aims to present research pertaining to the effect of angiotensin receptor-neprilysin double blocker on blocking the inflammatory mechanism mediated by NLRP3 inflammasome on hypertensive nephropathy. ARNI has not only been found to improve cardiac function but is also associated with a reduction in progressive deterioration of kidney function owing to hypertension by exerting anti-inflammation, anti-autophagy, anti-fibrosis and anti-Golgi’s apparatus. We hypothesized that administration of ARNI is more effective than valsartan alone in slowing progression of hypertensive renal disease. Methods Rat models with spontaneous hypertension were randomized into a no treatment group, valsartan group (60 mg/kg), ARNI group (70 mg/kg) or ARNI + A779 group (70 mg/kg + 400ng/kg) daily by gavage. Sprague-Dawley rats were subjected to the control conditions (without hypertension and treatment). The kidney tissue analyses were performed after 12 weeks. We detected the expression levels of NLRP3 and casepase-1 in kidney tissue, and NLRP3 levels in human embryonic kidney cells which were induced by ang II as hypertension cell model by Real-Time Polymerase Chain Reaction. To analyze the impact of ARNI on autophagy, we performed western blot analysis on renal tubules to measure the protein expression of NLRP3 inflammasome, and to measure the protein expression of P62 and LC3. Masson 3 staining method was used to stain renal fibrosis. Immunohistochemistry was performed to determine the expression sites of NLRP3. The Golgi apparatus in morphology of renal tubular cells was determined by transmission electron microscope. Results The untreated hypertensive renal disease rats exhibited tubular and glomerular damage, downregulation of pro-inflammatory, pro-autophagy, pro-fibrotic and pro-Golgi’s apparatus pathways. ARNI administration improved renal function and histology changes and attenuated most of the molecular markers of inflammation, autophagy, fibrosis and Golgi’s apparatus. Conclusions ARNI activation attenuates renal complications of arterial hypertension by reduction of kidney inflammation through selective actions requiring the renal tubular epithelium but not the glomerular endothelial cells and the circumferential mesangial interposition cell Angiotensin Receptor. ARNI was more effective than valsartan therapy alone in delaying the progression of hypertensive renal disease.

Nanoparticle-mediated RNA interference of angiotensinogen decreases blood pressure and improves myocardial remodeling in spontaneously hypertensive rats

Chronic Reduction in Paraventricular Nucleus (PVN) AT1R Expression by AAV‐mediated Transfer of a Small Hairpin RNA (shrna) Produces a Decrease in Blood Pressure in Spontaneously Hypertensive Rats

Abstract 394: Chronic Knockdown of the NTS AT1R Increases Circulating Inflammatory-Endothelial Progenitor Cells Ratio and Exacerbates Hypertension in the SHR

Chronic knockdown of the nucleus of the solitary tract AT1 receptors increases blood inflammatory-endothelial progenitor cell ratio and exacerbates hypertension in the spontaneously hypertensive rat.

Evidence for A Depressor Action of At1 Receptors in the Nucleus of the Solitary Tract (Nts)

Losartan Reduced Connexin43 Expression in Left Ventricular Myocardium of Spontaneously Hypertensive Rats

Effect of GPE-AGT Nanoparticle Shrna Transfection System Mediated RNAi on Early Atherosclerotic Lesion.

Effects of Antisense Oligonucleotides of Β1-Adrenergic Receptor Mrna on Cardiac Extracelluar Matrix and Left Ventricular Function in Spontaneously Hypertensive Rats

Prevention of myocardial fibrosis by using nitrendipine to the spontaneously hypertensive rats

Recombinant Adeno-Associated Virus-Mediated Delivery of Antisense Angiotensin II Receptor 1 Gene Attenuates Hypertension Development.

Effects of Exercises Training and Β1 Adrenoreceptor Antisense Gene Therapy on Blood Pressure and Cardiac Function in Spontaneously Hypertensive Rats

Alteration of RhoA Prenylation Ameliorates Cardiac and Vascular Remodeling in Spontaneously Hypertensive Rats.

Protection Effect of Β_1 Receptor Mrna Antisense Inhibition on Heart of Renal Hypertensive Rats

Targeted Inhibition of CTGF by RNA Interference Restrain Renal Fibrosis

Angiotensin Receptor Neprilysin Inhibition mediates Renal Protection by ARNI (Sacubatril Valsartan) in Rats with Spontaneous Hypertension

A1421 AHU377+valsartan (LCZ696) Modulates RAS Components in the Cardiac and Aorta of Female Spontaneously Hypertensive Rats Compared with Valsartan

O52 KIDNEY ARTERIOLAR RESPONSES TO LIVER-TARGETED SMALL INTERFERENCE RNA (SIRNA) TARGETING ANGIOTENSINOGEN IN DIABETIC RATS: COMPARISON WITH OTHER RENIN-ANGIOTENSIN SYSTEM BLOCKERS

TRV027 REDUCES BLOOD PRESSURE IN SHR AND RESTORES VENTRICULAR HYPERTROPHY BY AFFECTING CONNEXIN 43 PATHWAY

Effects of β1 Adrenoceptor Antisense on Blood Pressure, Preprorenin mRNA and Plasma Ang Ⅱ in Hypertensive Rats

Protective effect of novel angiotensin receptor neprilysin inhibitor S086 on target organ injury in spontaneously hypertensive rats

O101 THE ANGIOTENSIN II TYPE 1 RECEPTOR-BIASED AGONIST REDUCES BLOOD PRESSURE IN SPONTANEOUSLY HYPERTENSIVE RATS AND RESTORES VENTRICULAR HYPERTROPHY BY AFFECTING THE CONNEXIN 43 PATHWAY